On 31 March 2022, the Boards of InnovaDerma and Brand Architekts announced that they had reached agreement on the terms and conditions of a recommended cash and shares Merger pursuant to which Brand Architekts will acquire the entire issued and to be issued ordinary share capital of InnovaDerma. The Merger is to be effected by means of a Court-sanctioned scheme of arrangement between InnovaDerma and the Scheme Shareholders under Part 26 of the Companies Act 2006.
Publication and posting of the Scheme Document
The Perivan Shareholder communications team was delighted to work with finnCap who acted as Financial Adviser, Rule 3 Adviser and Corporate Broker to InnovaDerma and Singer Capital Markets who acted as Financial Adviser, Nominated Adviser and Corporate Broker to Brand Architekts on the
Production of the 100-page scheme document containing the full terms and conditions of the Merger and associated ancillary documents which were successfully published on 25th April.
Perivan specialise in the production and publication of financial documents relating to shareholder and investor communications for quoted companies, private companies and open and closed-ended funds.